Author： Rosser Charles J Urquidi Virginia Goodison Steve
Publisher： Future Medicine
ISSN： 1752-0363
Source： Biomarkers in Medicine, Vol.7, Iss.5, 2013-10, pp. : 779-790
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Bladder cancer is one of the most prevalent cancers worldwide. Early detection of bladder tumors is critical for improved patient outcomes. The standard method for detection and surveillance of bladder tumors is cystoscopy with urinary cytology. Limitations of cystoscopy and urinary cytology have brought to light the need for more robust diagnostic assays. Ideally, such assays would be applicable to noninvasively obtained, voided urine, and be designed not only for diagnosis, but also for monitoring disease recurrence and response to therapy. Consequently, the development of a noninvasive urine-based assay would be of tremendous benefit to both patients and healthcare systems. This article reports some of the more prominent urine-based biomarkers reported in the literature. In addition, some new technologies that have been used to identify novel urinary biomarkers are highlighted.
Related content
Imaging in Bladder Cancer: Present Role and Future Perspectives
Urologia Internationalis, Vol. 85, Iss. 4, 2010-10 ,pp. :
Access to resources
Recommend
Metastatic Small Intestinal Cancer of the Urinary Bladder
Case Reports in Oncology, Vol. 3, Iss. 3, 2010-09 ,pp. :
Cancer of the Urinary Bladder Neovagina in a Patient with Morris’ Syndrome
Oncology Research and Treatment, Vol. 31, Iss. 1-2, 2008-01 ,pp. :
By Heicappell R. Schostak M. Müller M. Miller K.
Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 60, Iss. 4, 2000-08 ,pp. :